[1]
|
Xu J,Fan J,Qin X,et al.Chinese guidelines for the diagnosis and comprehensive treatment of colorectal liver metastases (version 2018)[J].J Cancer Res Clin Oncol,2019,145:725-736. |
[2]
|
Zheng RS,Zhang SW,Zeng HM,et al.Cancer incidence and mortality in China,2016[J].Journal of the National Cancer Center,2022,2:1-9. |
[3]
|
Giannis D,Sideris G,Kakos CD,et al.The role of liver transplantation for colorectal liver metastases:A systematic review and pooled analysis[J].Transplant Rev(Orlando),2020,34:100570- 100570. |
[4]
|
Norén A,Sandström P,Gunnarsdottir K,et al.Identification of inequalities in the selection of liver surgery for colorectal liver metastases in Sweden[J].Scand J Surg,2018,107:294-301. |
[5]
|
Siegel RL,Miller KD,Goding Sauer A,et al.Colorectal cancer statistics,2020[J].CA Cancer J Clin,2020,70:145-164. |
[6]
|
WolfAMD,FonthamETH,ChurchTR,et al.Colorectal cancer screening for average-risk adults:2018 guideline update from the American Cancer Society[J].CA Cancer J Clin,2018,68:250-281. |
[7]
|
Van CutsemE,CervantesA,AdamR.et al.ESMO consensus guidelines for the management of patients with metastatic colorectal cancer[J].Ann Oncol,2016,27:1386-1422. |
[8]
|
陈小玲,焦晓多,伍勇,等.肝癌患者血清中透明质酸、层粘蛋白、Ⅵ型胶原的测定及临床意义[J].临床和实验医学杂志,2010,9:1041-1043. |
[9]
|
Johnson PJ, Berhane S, Kagebayashi C,et al.Assessment of liver function in patients with hepatocellular carcinoma:A new evidence-based approach-the ALBI grade[J].J Clin Oncol,2015,33:550-558. |
[10]
|
Yagyu T,Saito H,Sakamoto T,et al.Preoperative Albumin-Bilirubin Grade as a Useful Prognostic Indicator in Patients With Pancreatic Cancer[J].Anticancer research, 2019,39:1441- 1446. |
[11]
|
段丽宁,常宁,赵亚静,等.血清肿瘤标志物联合肝功能指标检测对结肠癌肝转移的诊断价值[J].中华肿瘤防治杂志,2022,29:1206-1210. |
[12]
|
马运宾,刘骞.术前血清CEA、CA19-9、CA50联合检测在结直肠癌肝转移预测中的应用[J].中华结直肠疾病电子杂志,2018,7:453-457. |
[13]
|
Xue J,Li J,Liang J,et al.The prevalence of mild cognitive impairment in China:a systematic review[J].Aging and disease,2018,9:706-715. |
[14]
|
惠鹏, 刘连 新, 梁英 健. 结直 肠癌 肝转 移的 分子 机制 研究 进展[J]. 中国 普外 基础 与临 床杂 志,2019,26:758-763. |
[15]
|
Cong ZJ, Hu LH, Ji JT, et al.A long-term follow-up study on the prognosis of endoscopic submucosal dissection for colorectal laterally spreading tumors[J].Gastrointest Endosc,2016, 83:800-807. |
[16]
|
王娜.术前血清CEA、CA19-9、CA50、AFP和TPS检测对结直肠癌肝转移的预测价值[J].中国肛肠病杂志,2021,41:1-3. |
[17]
|
Lee JH,Lee SW.The roles of carcinoembryonic antigen in liver metastasis and therapeutic approaches[J]. Gastroenterol Res Pract,2017,2017:7521987. |
[18]
|
Duffy MJ,van Dalen A,Haglund C,et al.Tumor markers in colorectal cancer:European Group on Tumor Markers (EGTM) guidelines for clinical use[J].Eur J Cancer,2007,43:1348-1360. |
[19]
|
Misiakos EP,Karidis NP,Kouraklis G.Current treatmentfor colorectal liver metastases[J].World J Gastroenterol,2011,17:4067-4075. |
[20]
|
邓玉雪, 官玲玲.比较几种血清肿瘤标志物在结直肠癌及其肝转移的诊断价值[J].中国实用医药, 2017,12:79-80. |
[21]
|
苏阜力,张补文.血清酶活性联检在肝病中的应用[J].实用医技杂志,2006,14:2435-2436. |
[22]
|
赵杰,余海波,朱运海,等.肝癌根治术前GGT, ALT/AST和术后临床病理特征与预后的关系[J].中华普通外科杂志,2019,34:328-331. |
[23]
|
鲁立峰,盛勤松,邹德胜,等.结直肠癌切除联合射频消融对同时性结直肠癌肝转移临床指标、安全性及预后的影响[J].中华全科医学,2018,16:736-739. |
[24]
|
白傲雪,张宁苏,董野等.结直肠癌肝转移的相关因素[J].实用中医内科杂志,2020,34:120-123. |
[25]
|
Wu XZ,Ma F,Wang XL.Serological diagnostic factors for liver metastasis in patients with colorectal cancer[J].World J Gastroenterol,2010,16:4084-4088. |
[26]
|
敬蕾,常玉霞,党元娜.胰腺癌术后发生肝转移的影响因素分析[J].实用癌症杂志,2022,37:108-110. |
[27]
|
Thibaut MM,Sboarina M,Roumain M,et al.Inflammation-induced cholestasis in cancer cachexia[J].J Cachexia Sarcopenia Muscle,2021,12:70-90. |
[28]
|
Baracos VE,Martin L,Korc M,et al.Cancer-associated cachexia[J].Nat Rev Dis Prim, 2018,4:17105. |